Recent observations associate one specific ILC subset, the IL‐22 producing ILC3, with reduced sensitivity to graft‐versus‐host disease (GVHD) after allo‐hematopoietic cell transplantation (HCT) 9, 10. This evidence concerns the gene IL22 and graft versus host disease.